Curaleaf CEO talks unsolicited offer to buy Aurora Cannabis

Watch on YouTube ↗  |  August 18, 2026 at 22:18  |  3:57  |  CNBC
Speakers
Boris Jordan — CEO, Galaxy Digital
Tim Seymour — Seymour Asset Management, Fast Money Trader

Summary

Curaleaf CEO Boris Jordan discusses his unsolicited bid for Aurora Cannabis and why he sees it as a strong strategic fit. He argues Curaleaf needs Aurora's Canadian production capacity to supply its European/Asian distribution, while Aurora's standalone business is shrinking. Tim Seymour adds that the deal highlights multiple bullish signals for the cannabis industry.

  • Curaleaf made an unsolicited offer for Aurora Cannabis, and Aurora formed a special committee.
  • Boris Jordan says Curaleaf has strong Europe/Asia distribution but is supply-constrained, while Aurora's Canadian facilities can nearly double productivity.
  • Boris says Aurora's Canadian and Australian businesses are shrinking, with repeated earnings disappointments and a $6 billion writedown.
  • The proposed deal is structured as 80% stock and 20% cash.
  • Tim Seymour highlights cleaned-up Canadian balance sheets, excess capacity, Europe's roughly 27% growth, Curaleaf free cash flow, and a potential Nasdaq listing as bullish industry subplots.
Ideas
Boris Jordan CEO, Galaxy Digital 0:55
Curaleaf gets supply and European re-rating upside.
Curaleaf is strategically strong because it has the largest cannabis distribution in Europe/Asia but is supply-constrained; Aurora's Canadian facilities could be nearly doubled in productivity to supply those networks. Curaleaf also has massive tailwinds from double-digit Europe/international growth and potential European regulatory changes that could trigger a significant re-evaluation.
CURLF HIGH
Tim Seymour Seymour Asset Management, Fast Money Trader 1:28
Cannabis industry has multiple bullish catalysts.
The Curaleaf-Aurora bid highlights multiple bullish subplots for the cannabis industry: Canadian companies like Aurora have cleaned up balance sheets, excess capacity now has international destinations, Europe is growing about 27% year over year, Curaleaf has free cash flow for cash-plus-stock M&A, and consolidation could put a Nasdaq listing at stake.
MSOS MED
Boris Jordan CEO, Galaxy Digital 3:01
Aurora standalone fundamentals are deteriorating.
Aurora Cannabis is struggling as a standalone company: Canadian and Australian businesses are shrinking quarter after quarter, it has repeatedly disappointed earnings, and it has written off $6 billion of shareholder value, so the asset is better transferred to Curaleaf.
ACB HIGH
Up Next
6:47
Australia’s Stock Market Seen as AI Haven
Bloomberg Markets · Aug 18
46:08
Trump Claims Hormuz as US Territory…High Interest Rate Pressure Continues Amid Middle East Instability [Wall Street Newsletter]
3PRO TV (삼프로TV) · Aug 18
49:00
Global Bond Slump Raises Fed Questions | Bloomberg Businessweek Daily 8/18/2026
Bloomberg Markets · Aug 18
44:15
Crypto CEOs, Surviving Crypto Winter | Bloomberg Crypto 8/18/2026
Bloomberg Markets · Aug 18
8:07
Long-Term Debt Costs Soar to Highest in Decades as Bonds Slump
Bloomberg Markets · Aug 18

This CNBC video, published August 18, 2026, features Boris Jordan, Tim Seymour discussing CURLF, MSOS, ACB. 3 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Boris Jordan, Tim Seymour  · Tickers: CURLF, MSOS, ACB